Q32 Bio
QTTB
QTTB
90 hedge funds and large institutions have $37.8M invested in Q32 Bio in 2024 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 22 increasing their positions, 10 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
14.75% more ownership
Funds ownership: 75.53% → 90.27% (+15%)
88% less call options, than puts
Call options by funds: $62K | Put options by funds: $498K
91% less capital invested
Capital invested by funds: $406M → $37.8M (-$368M)
Holders
90
Holding in Top 10
4
Calls
$62K
Puts
$498K
Top Buyers
| 1 | +$2.4M | |
| 2 | +$1.98M | |
| 3 | +$418K | |
| 4 |
RhumbLine Advisers
Boston,
Massachusetts
|
+$334K |
| 5 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$280K |
Top Sellers
| 1 | -$18M | |
| 2 | -$8.48M | |
| 3 | -$7.27M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$4.77M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$3.42M |